Abstract
Malignant melanoma is a malignant tumor originating from the transformation of melanocytes or nevus cells. These cells, mostly arising from the neural crest are not only encountered in the skin and the mucous membranes surrounding the skin, but also in the uvea, the retina and the central nervous system. Nonetheless, between 85% and 90% of melanomas arise on the outer skin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Katsambas A, Nicolaidou E (1996) Cutaneous malignan melanoma and sun exposure. Recent developements in Epidemiology. Arch Dermatol 132: 444–450
Andreassi L, Balda B-R, Landi G (1993) Current trends in the treatment of melanoma. Skin Cancer 8: 103–113
Bachter D, Balda B-R, Vogt H, Büchels H (1996) Die “sentinel” Lymphonodektomie mittels Szintillationsdetektor. Hautarzt 47: 754–758
Bachter D, Balda B-R, Vogl H, Büchels H (1998) Primary therapy of malignant melanomas: sentinel lymphadenectomy. Int J Derm 37: 278–282
Balda B-R, Herrmann R (1995) Neoplasien der Haut. In: Huhn D, Herrmann R (eds) Medikamentöse Therapie maligner Erkrankungen. 3rd. Fischer, Stuttgart, p 393–405
Berger W, Ebling L, Micksche M (1998) Chemoresistance of Human Malignant Melanoma: Cellular and Molecular Aspects. Onkologie 21: 105–110
Elsässer-Beile U, Schöpf E, Neumann HA, Drews H, Hundhammer K, Balda B-R (1987) Rekombiniertes Leukozyten-A-Interferon beim metastasierten malignen Melanom. Dtsch med Wschr 112: 373–377
Enk AH, Nashan D, Knop J (1997) Therapie von Lungenmetastasen des malignen Melanoms mit inhalativem IL-2. Hautarzt 48: 894–896
Falkson CI, Ibrahim J, Kirkwood JM, Coates AS, Atkins MB, Blum RH (1998) Phase III Trial of Dacarbazine versus Dacarbazine with Interferon a-2b versus Dacarbazine with Tamoxifen versus Dacarbazine with Interferon u.-2b and Tamoxifen in Patients with Metastatic Malignant Melanoma: An Eastern Cooperative Oncology Group Study. J Clin Oncol 16: 1743–1751
Kirkwood JM, Hunt-Straderman M, Ernstorff MS, Smith TJ, Borden, Blum RH (1996) Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.1 Clin Oncol 14: 7–17
Morton DL, Wen DR, Cochran AJ (1990) Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. An alternative to routine elective lymphadenectomy or “watch and wait”. Surg Oncol Clin North Am 1: 247–259
Starz H, Balda B-R, Stichels H (1998) Sentinel-Lymphonodektomie bei malignen Melanomen. Eine vorläufige Bilanz aus histomorphologischer Sicht. In: Garbe C, Rassner G (eds) Dermatologie. Leitlinien und Qualitätssicherung für Diagnostik und Therapie. Springer, Heidelberg, pp 274–277
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Balda, B.R. (2000). Malignant Melanoma. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03835-2_60
Download citation
DOI: https://doi.org/10.1007/978-3-662-03835-2_60
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-03837-6
Online ISBN: 978-3-662-03835-2
eBook Packages: Springer Book Archive